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Summary
Antigenic variation in Trypanosoma brucei has
selectedfortheevolutionofamassivearchiveofsilent
Variant Surface Glycoprotein (VSG) genes, which are
activated by recombination into specialized expres-
sion sites. Such VSG switching can occur at rates
substantially higher than background mutation and is
dependentonhomologousrecombination,acoreDNA
repair reaction.Akey regulator of homologous recom-
bination is BRCA2, a protein that binds RAD51, the
enzyme responsible for DNA strand exchange. Here,
weshowthatT.bruceiBRCA2hasundergonearecent,
striking expansion in the number of BRC repeats,
a sequence element that mediates interaction with
RAD51. T. brucei BRCA2 mutants are shown to be
signiﬁcantly impaired in antigenic variation and
display genome instability. By generating BRCA2 vari-
ants with reduced BRC repeat numbers, we show
that the BRC expansion is crucial in determining the
efficiency of T. brucei homologous recombination
and RAD51 localization. Remarkably, however, this
appearsnottobeamajordeterminantoftheactivation
of at least some VSG genes.
Introduction
African trypanosomes, in common with many pathogens,
survive in the face of host immune responses by undergo-
ing antigenic variation, the continuous changing of patho-
gen surface antigens. Successive waves of immune
response to the variant surface antigens eradicate part but
notallofthepathogenpopulation,lengtheningtheinfection
and enhancing transmission. A number of strategies for
antigenic variation have evolved (Deitsch et al., 1997), but
acommonapproachistheuseofgeneconversion(Palmer
and Brayton, 2007). Trypanosoma brucei antigenic varia-
tion involves changes in the composition of a dense,
protective coat composed of Variant Surface Glycoprotein
(VSG) and can occur at very high rates (Turner and Barry,
1989), a trait shared with other pathogens (Barry and
McCulloch, 2001; Criss et al., 2005). T. brucei appears
remarkable, however, in the extent to which it has invested
ingeneconversion(forrecentreviews,seeHornandBarry,
2005; Taylor and Rudenko, 2006).
The T. brucei genome contains greater than 1000 VSG
genes (Berriman et al., 2005; Marcello and Barry, 2007),
an archive of potential variant surface proteins larger than
in any other organism described to date. The genome is
composed of 100 or so minichromosomes, a few inter-
mediate chromosomes and 11 megabase chromosomes.
VSGs are found adjacent to the telomere on all T. brucei
chromosome classes, but the majority of the archive is
present in subtelomeric arrays on the megabase chromo-
somes. Each trypanosome cell normally expresses only
one VSG at a time, from telomeric VSG expression sites
(ESs).ThemainrouteofVSGswitchingisthemovementof
the silent VSG genes into the ESs (Robinson et al., 1999).
Primarily, such recombination reactions involve gene con-
version, generating a copy of a silent VSG and displacing
the ES VSG. Less common are cross-overs in which
chromosome ends are exchanged, activating a new VSG
without copying. VSG gene conversions appear to operate
inahierarchy,whichisthoughttobeimportantinextending
the infection (Pays, 1989; Barbet and Kamper, 1993).
Telomere-proximal VSG genes are activated early, fol-
lowed by functional array genes (Morrison et al., 2005).
Finally, novel mosaic VSGs are generated by segmental
gene conversion reactions involving VSG pseudogenes
and gene fragments (Thon et al., 1990; Kamper and
Barbet, 1992). Such damaged VSGs represent the huge
majority of the VSG archive, and are likely to be a major
determinant of the function and success of T. brucei anti-
genic variation (Kamper and Barbet, 1992; Barbet and
Kamper, 1993; Marcello and Barry, 2007). In contrast to a
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locus for antigenic variation is found (Criss et al., 2005;
Palmer and Brayton, 2007), T. brucei possesses multiple
VSG ESs (Becker et al., 2004). Only one ES is fully tran-
scribed at a time, but VSG switches can occur by inacti-
vating the active ES and activating a previously silent ES,
though the factors that mediate this process are still being
determined (Pays, 2005; Hughes et al., 2007).
Homologous recombination performs core functions in
all cells by reversing genotoxic damage and ensuring the
completion of DNA replication (Sung and Klein, 2006). It
can also provide for telomere maintenance, and is needed
for genetic exchange during meiosis. Homologous re-
combination appears to act in T. brucei VSG switching,
as mutation of RAD51 (McCulloch and Barry, 1999),
the central eukaryotic enzyme of homologous strand
exchange, impairs the process, as does mutation of a
RAD51-related protein, RAD51-3 (Proudfoot and McCul-
loch, 2005). Such a reliance on a core DNArepair process
for the specialized recombination of antigenic variation
is true also for Neisseria sp. (Sechman et al., 2005).
However, whether speciﬁc factors for antigenic variation
exist, and whether antigenic variation has imposed adap-
tationsonthehomologousrecombinationmachinery,have
been little explored. One stage at which such features
mightbeseenisintheregulationofRAD51function,which
is inﬂuenced by a wide range of factors (Sung and Klein,
2006).OneoftheseisBRCA2,theproteinencodedbyone
human breast cancer susceptibility gene (Narod and
Foulkes, 2004). BRCA2 homologues are widespread in
eukaryotes (Warren et al., 2002; Lo et al., 2003), and
analyses in the nematode Caenorhabditis elegans (Petal-
corin et al., 2007) (CeBRC-2), in the fungus Ustilago
maydis (Kojic et al., 2002; Yang et al., 2005) (Brh2) and in
the plant Arabidopsis thaliana (Dray et al., 2006) suggest
that at least one function is conserved with a role initially
described in mammals: RAD51 interaction via BRC repeat
motifs in BRCA2 (Bork et al., 1996; Wong et al., 1997;
Chen et al., 1998; Marmorstein et al., 1998). At least one
BRC repeat has been described in all characterized
BRCA2 homologues (Lo et al., 2003). Mammalian BRCA2
has eight non-identical BRC repeats (Lo et al., 2003), at
least six of which bind RAD51 in humans (Wong et al.,
1997; Chen et al., 1998; Marmorstein et al., 1998). Simi-
larly, A. thaliana BRCA2 has four degenerate BRC motifs,
some of which bind RAD51 (Dray et al., 2006). In contrast,
C. elegans BRCA2/CeBRC-2 (Martin et al., 2005) and U.
maydis BRCA2/Brh2(Kojic et al., 2006) contain only a
single RAD51-binding BRC repeat. In addition to binding
RAD51 via the BRC repeats, BRCA2 interacts with RAD51
through unrelated sequences in a number of organisms
(Mizuta et al., 1997; Sharan et al., 1997; Esashi et al.,
2005; Petalcorin et al., 2007; Zhou et al., 2007). In
mammals and C. elegans, non-BRC repeat binding
appears to be speciﬁc for RAD51 ﬁlaments (Davies and
Pellegrini, 2007; Esashi et al., 2007; Petalcorin et al.,
2007), whereas the BRC repeats can bind both RAD51
monomers and ﬁlaments (Galkin et al., 2005; Shivji et al.,
2006).
Previous work has suggested that a BRCA2 homologue
in T. brucei contains a remarkable expansion in BRC
repeat number (Warren et al., 2002; Lo et al., 2003).
Here, we have examined BRCA2 from T. brucei and
related kinetoplastid parasites, and show that this is a
recent evolutionary adaptation. To test if this is due to the
use of homologous recombination in antigenic variation,
we have generated T. brucei BRCA2 mutants and vari-
ants of the protein with alterations in conserved motifs,
including the BRC repeats. We show, ﬁrst, that BRCA2
acts in DNA repair, recombination and antigenic variation
in T. brucei. Second, we demonstrate that the BRC repeat
number or sequence composition of BRCA2 is critical
in general repair and recombination but, remarkably,
appears not to be important in the activation of early
expressed VSG genes.
Results
A recent evolutionary expansion of BRC repeats in
T. brucei BRCA2
Trypanosoma brucei and related, evolutionarily diverged
kinetoplastid parasites each encode a single BRCA2
homologue (Warren et al., 2002; Lo et al., 2003). These
proteins possess signiﬁcant sequence similarity with
BRCA2 homologues from vertebrates, plants and fungi in
the DSS1-DNA binding region (Lo et al., 2003), within
which most domains are conserved (Yang et al., 2002; C.
Hartley and R. McCulloch, submitted). Regulation of the
kinetoplastid BRCA2 proteins’ function by DSS1 is also
likely to be conserved, as a homologue of DSS1 is also
identiﬁable in each kinetoplastid genome and the
BRCA2–DSS1 interacting residues (Yang et al., 2002) are
conserved in each protein. Finally, it seems likely that the
kinetoplast BRCA2 proteins are nuclear, as localization
signals can be detected in the T. brucei (Fig. 2A) and
T. cruzi polypeptide sequences (data not shown).
The only other clear similarity between kinetoplastid
and other eukaryotic BRCA2 proteins lies in the BRC
repeats (Bork et al., 1996; Bignell et al., 1997). However,
the BRC repeat number and organization in T. brucei are
highly unusual (Fig. 1 and Table S1). In general terms, it
appears that the simpler the organism, the smaller the
number of BRC repeats in BRCA2. In illustration, of 14
BRCA2 proteins identiﬁed in the genomes of a diverse
range of unicellular organisms (Table S1), nine have
between one and three BRC repeats. Conversely, of eight
multicellular organisms, seven have three or more BRC
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repeats, the plant A. thaliana has four, and the insects
Drosophila melanogaster and Anopheles gambiae have
three and 10 respectively. It seems plausible therefore
that developmental complexity and/or increased genome
size exerts an evolutionary pressure for greater numbers
of repeats due to greater demands for control of homo-
logous recombination. C. elegans BRCA2/CeBRC-2
appears to be an exception, however, with only one BRC
repeat, although the reasons for this are unclear. Some
protists are also exceptions, displaying greater BRC
repeat numbers. Trichomonas vaginalis BRCA2 has 14
predicted BRC repeats, which may be related to the large
genome size of this parasite (Carlton et al., 2007).
However, this does not always provide an explanation, as
Apicomplexan BRCA2 proteins, such as in Cryptospo-
ridium parvum, Plasmodium falciparum and Toxoplasma
gondii, have between six and eight predicted BRC repeats
and T. brucei BRCA2 is predicted to contain 15.
The BRC repeats of T. brucei BRCA2 are unusual in
two further ways. First, unlike the broad conservation of
increased BRC repeat number in the apicomplexans,
BRCA2 of T. brucei is distinct from closely related
kinetoplastids (Fig. 1). T. cruzi and Leishmania major
diverged from T. brucei 200–300 million years ago
(Overath et al., 2001) and each BRCA2 has two non-
identical BRC repeats. Even more strikingly, two Trypa-
nosoma species, T. vivax and T. congolense, that belong
to the same salivarian clade as T. brucei (Cortez et al.,
2006) are predicted to possess BRCA2 proteins with
only one and three BRC repeats respectively. The
second unusual feature of T. brucei BRCA2 is that the 15
predicted BRC repeats are arranged as a tandem array
in which 14 are identical in sequence [in fact, each
repeat of the array is 44 amino acids (132 bp) in length,
longer than the 35-amino-acid BRC motif; Fig. 1]. In all
other organisms in which BRCA2 has more than one
BRC repeat, with the notable exception of T. congolense,
they are distributed unevenly in the polypeptide
sequence and are degenerate in sequence outwith the
key functional residues (Lo et al., 2003).
Before examining why T. brucei BRCA2 has such
unusual structural organization, we checked that the
above predictions do not arise from genome sequence
compilation errors. We ﬁrst performed minisatellite variant
repeat (MVR) mapping on clones of a number of T. b.
brucei strains and T. brucei subspecies (Fig. 2). In all
cases, MVR PCR yielded the expected ladder of
products. In T. b. brucei strain Lister 427, the largest
product was equivalent to 12 BRC repeats and a pro-
nounced, smaller band was generated with 10 repeats,
suggesting two distinct BRCA2 alleles (Fig. 2A). In the T.
b. brucei genome sequence strain TREU927, which was
predicted to have 15 BRC repeats, each allele contained
11 repeats, while a further T. b. brucei strain, EATRO795,
contained two alleles with 12 BRC repeats (Fig. 2C). MVR
Fig. 1. Conservation of BRC repeats in
eukaryotic BRCA2. The upper diagrams show
the number and location of BRC repeat motifs
(black bars) in BRCA2 proteins from a
number of eukaryotes; the sizes of the
BRCA2 polypeptides (in amino acids) are
indicated. The boxed diagram shows
conservation of BRC repeats in
trypanosomatid BRCA2 proteins relative to
H. sapiens; critical residues for RAD51
binding inferred by Lo et al. (2003) are
indicated as
a BRC ﬁngerprint (O, polar; +, positively
charged; I, hydrophobic; i, small hydrophobic).
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ense suggested a lower number of BRC repeats than in T.
b. brucei: each contained a larger allele with eight repeats
and a smaller allele with ﬁve or six repeats respectively
(Fig. 2B and C). To conﬁrm these ﬁndings, we performed
Southern mapping of BRCA2, demonstrating two distinct
BRCA2 alleles of the expected size in both T. b. brucei
Lister 427 (Fig. 2D) and T. b. gambiense (data not
shown). Next, we PCR-ampliﬁed the BRC-repeat region
from BRCA2 from each of the above T. brucei strains and
subspecies, as well as from T. vivax and T. congolense,
and sequenced the products after cloning. For T. brucei,
this conﬁrmed the predicted BRC repeat organization: in
all cases, the most C-terminal coding repeat (‘BRC repeat
15’, Fig. 1) was degenerate in sequence relative to all the
upstream repeats, which were virtually identical at the
nucleotide level (< 1 base change per repeat, on average)
both within a given BRCA2 gene and between strains/
subspecies (data not shown). BRCA2 from T. vivax was
conﬁrmed as containing a single BRC repeat, while the
T. congolense strain used here (TREU1457) contained
two very similar (5 bp differences) repeats, rather than the
three predicted from genome sequencing (strain IL3000).
Taken together, these data indicate that the BRC repeat
organization in T. brucei BRCA2 is a recent evolutionary
expansion, generating numbers that, while variable
between isolates, are signiﬁcantly higher than BRCA2
orthologues in closely related kinetoplastid parasites.
T. brucei BRCA2 acts in homologous recombination
and antigenic variation
To examine the functions of BRCA2 in T. brucei we gen-
erated null mutants in bloodstream stage cells, deleting
the entire BRCA2 ORF (Fig. 3) by two rounds of transfor-
mation, replacing the two alleles with constructs encoding
resistance to blasticidin and puromycin. This was per-
formed in both the Lister 427 T. brucei strain and in a
transgenic derivative named 3174 (McCulloch et al.,
1997; McCulloch and Barry, 1999; Proudfoot and
McCulloch, 2005), which allows analysis of switching
mechanisms. In each strain, we independently derived
two lines of BRCA2 heterozygous (+/-) and homozygous
(-/-) mutants, and re-expressed BRCA2 in one of the -/-
mutants (-/-/+). In all cases, the mutants (Fig. 3B) and
re-expressers were conﬁrmed by Southern mapping and
reverse transcription polymerase chain reaction (RT-
PCR) (data not shown). Consistent with a role for BRCA2
in DNA repair, the -/- mutants displayed increased
sensitivity to methyl methanesulphonate (MMS) or
bleomycin-induced DNA damage relative to wild type
(WT), +/- or -/-/+ cells (C. Hartley and R. McCulloch,
Fig. 2. Analysis of BRC repeat number in T. brucei BRCA2.
A. The predicted domain organization of BRCA2 from T. b. brucei strain TREU927 is shown; 15 putative BRC repeats are indicated, as is the
DSS1-DNA-binding domain (DBD) and two putative nuclear localization signals (NLSs). Arrows denote oligonucleotide primers used in
minisatellite variant repeat (MVR) mapping.
B. MVR mapping of BRC repeat number in genomic DNA from T. b. brucei strain Lister 427, T. b. rhodesiense isolate Eliane and T. b.
gambiense isolate 222; size markers are indicated.
C. A summary of the numbers of BRC repeats in the two alleles of BRCA2 in T. b. brucei (Tbb) strains TREU927, Lister 427 and EATRO795,
and in isolates of the T. brucei subspecies T. b. rhodesiense (Tbr; Eliane) and T. b. gambiense (Tbg; 222); BRC numbers were inferred from
MVR mapping (above), Southern analysis and sequencing of PCR clones of the BRC repeat regions.
D. A Southern blot of restriction-digested genomic DNA from T. b. brucei strain Lister 427, probed with the BRCA2 ORF.
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replication or cell division defects not observed in mutants
of other T. brucei DNA repair and homologous recombi-
nation genes (C. Hartley and R. McCulloch, submitted).
To examine the contribution of BRCA2 to T. brucei
homologous recombination, the transformation efficiency
of WT, +/-, -/- and -/-/+ cells was compared following
electroporation with targeting constructs. In the Lister
427 mutants, we used linearized tub-HYG-tub plasmid,
which targets a hygromycin resistance gene to the
tubulin array, replacing an a tubulin ORF by homologous
recombination on terminal ﬂanking sequence (240 bp of
tubulin b–a intergenic sequence upstream, and 330 bp
of a–b intergenic sequence downstream). Transformants
were generated in the brca2-/- mutants 12.5- to 22.5-
fold less efficiently than the other cells (Fig. 3C). Very
similar results were found in 3174 mutants using an
equivalent plasmid in which HYG was replaced by a
phleomycin resistance gene (data not shown). In all
cases, examples of the brca2-/- transformants were
characterized by Southern blotting, which showed that
all integrations had targeted the tubulin array via homol-
ogy (data not shown). These results are comparable
with mutants of other T. brucei homologous recombina-
tion factors (RAD51, RAD51-3, RAD51-5 and MRE11)
(McCulloch and Barry, 1999; Conway et al., 2002;
Robinson et al., 2002; Proudfoot and McCulloch, 2005)
and indicate that BRCA2 acts in homologous plasmid
integration, but BRCA2-independent pathways also
operate.
We next used the mutant cell lines made in the 3174
strain to examine the ability of the brca2-/- mutants to
undergo antigenic variation. Measuring the efficiency at
which VSG-switched variants arose (Fig. 4A) indicated
that ablation of BRCA2 reduced the VSG-switching fre-
quency around 8- to 11-fold relative to the WT, +/- or -/-/+
cells. The extent of this switching impairment is very
similar to that seen in RAD51 and RAD51-3 mutants
(McCulloch and Barry, 1999; Proudfoot and McCulloch,
2005), conﬁrming that much of VSG switching involves
homologous recombination. Characterization of the reac-
tions that gave rise to VSG-switched variants indicated
that gene conversion and transcriptional switching events
could still be detected in the brca2-/- cells (Fig. 4B),
indicating that the reduced VSG switch frequency was
accounted for by impairment of both reaction pathways.
This surprising result is equivalent to VSG-switching
phenotypes observed in RAD51 and RAD51-3 mutants
(McCulloch and Barry, 1999; Proudfoot and McCulloch,
2005) and may indicate that BRCA2 acts in conjunction
with these factors in this process.
The BRC repeat organization of T. brucei B R C A 2i sa n
important determinant of homologous recombination
efficiency
To examine why T. brucei BRCA2 has evolved such an
unusual arrangement of BRC repeats, we generated a
number of BRCA2 variants (Fig. 5A). To test if BRCA2
with a single BRC repeat is competent in DNA repair
Fig. 3. Assaying the role of T. brucei BRCA2 in homologous recombination.
A. The complete BRCA2 ORF was deleted (triangle) in wild type (WT) bloodstream stage T. brucei cells and replaced by cassettes encoding
resistance to blasticidin (DBRCA2::BSD) or puromycin (DBRCA2::PUR).
B. A Southern blot of SacII- and StuI-digested genomic DNA from WT cells (two distinct BRCA2 alleles can be seen), and from two
independently generated heterozygous (+/-1, 2) and homozygous mutants (-/- 1, 2). Size markers (kb) and the positions of intact and
disrupted BRCA2 alleles are indicated.
C. To assay recombination, the number of transformants recovered (per 10
6 cells put on antibiotic selection) when the construct tub-HYG-tub
was electroporated into the parasite cell lines was measured; values shown are averages from three experiments, and bars indicate standard
errors. BRCA2 re-expressers (-/-/+) were generated by re-inserting the BRCA2 ORF into one of the -/- mutants.
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vivax (TvBRCA2), which naturally possesses a single
BRC repeat (Fig. 1). TvBRCA2 and T. brucei BRCA2
(TbBRCA2) share 26% overall sequence identity, rising
to 42% C-terminal to the BRC repeats. Sequence com-
parisons predict that TvBRCA2 will bind T. brucei
RAD51: the BRC repeat retains all the key residues for
RAD51 interaction predicted by Lo et al. (2003) (Fig. 1);
and the single RAD51 orthologue in each Trypanosoma
species share 79% sequence identity (87% similarity)
with each other, including conservation of all residues
predicted to bind BRC repeats (data not shown) (Lo
et al., 2003). We also manipulated the T. brucei BRCA2
gene, reducing the BRC repeat number to just one. In
this protein (1BRC) only the variant, C-terminal BRC
repeat (‘repeat 15’; Fig. 1) is retained, but all other parts
of BRCA2 are unaltered. Despite being distinct from the
upstream repeats, the C-terminal BRC peptide retains
residues predicted to be critical for binding RAD51
(Lo et al., 2003). Next, a truncated version of T. brucei
BRCA2 was generated (BRCrep) that encodes only the
BRC repeat region plus a C-terminal predicted nuclear
localization signal (NLS); all C-terminal sequence (includ-
ing the DSS1-DNA-binding domain) was deleted, as was
80-amino-acid N-terminal to the BRC repeats. Finally, a
BRCA2 variant was generated in which the BRCrep
polypeptide was translationally fused to the T. brucei
Replication Protein A (RPA) 50 kDa subunit, which is
homologous to the 70 kDa RPA-1 protein of other
eukaryotes and binds single-stranded DNA via a
conserved oligonucleotide/oligosaccharide binding fold
domain in Leishmania (Neto et al., 2007). This BRC–
RPA fusion is functionally equivalent to similar polypep-
tides examined in U. maydis (Kojic et al., 2005) and
mammalian cells (Saeki et al., 2006).
Each of the above variants, plus full-length TbBRCA2,
were expressed in one of the brca2-/- Lister 427 cell
lines by integration of the ORFs into the T. brucei tubulin
array. All were expressed using the same integration
construct, meaning that their level of expression, assum-
ing equal translation efficiencies, should be comparable
and correct integration was conﬁrmed by Southern
analysis (data not shown). Expression of most of the
proteins could be demonstrated by complementation of
phenotypic defects: BRC–RPA and TbBRCA2 reverted
the MMS sensitivity of the brca2-/- cells (C. Hartley and
R. McCulloch, submitted), TbBRCA2, TvBRCA2 and
1BRC reverted the replication/cell division defect of the
mutants (C. Hartley and R. McCulloch, submitted) and
all but BRCrep was active in VSG switching (see below).
Fig. 4. Assaying the role of T. brucei BRCA2 in VSG switching.
A. VSG-switching frequencies for wild-type T. brucei cells (3174.2; WT) were compared with two independently generated heterozygous
(+/-1, 2) and homozygous (-/- 1, 2) BRCA2 mutants, in addition to a cell line in which BRCA2 was re-expressed from the tubulin locus
(-/-/+). The values shown are the means of at least three independent experiments, and bars represent standard errors.
B. The mechanism of VSG switching used in each cell line was determined by assaying for the expression of hygromycin and G418
resistance from the antibiotic marker genes (HYG and NEO respectively) inserted around VSG-associated 70 bp repeat sequences (hatched
box) in the active VSG221 expression site (ES) in strain 3174 (diagram shows this gene arrangement; The ﬂag denotes promoter), as well as
using PCR to assess whether HYG, NEO or VSG221 had been removed by gene conversion or DNA deletion. The percentage of clones
that had undergone VSG switching by transcriptional (in situ) switching, gene conversion/deletion of HYG, NEO and VSG221 (ES gene
conversion/deletion) or gene conversion/deletion of only NEO and VSG221 (VSG gene conversion/deletion) for each cell line is shown;
bars denote standard errors, and switched variants that do not conform to the above mechanisms are indicated as ‘unknown’.
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gous recombination, the transformation efficiency of
tub-HYG-tub was compared in the different expresser
cell lines (Fig. 5B). As we have shown already (Fig. 3),
full-length TbBRCA2 caused reversion of the brca2-/-
integration defect, with transformation frequencies
equivalent to WT and +/- cells. In contrast, none of the
variant proteins functioned efficiently in this assay.
Although transformants arose in each expresser cell line
at slightly higher rates than -/- cells, in each case this
was signiﬁcantly lower (around 4–5) than the frequen-
cies seen in the WT or TbBRCA2 -/-/+ cell lines
(P-values < 0.001 for all variants; two-sample t-test).
This indicates that each is impaired in this pathway of
homologous recombination.
T. brucei BRCA2 with a single BRC repeat is impaired
in RAD51 focus formation
Phleomycin treatment and induction of a DNA double-
strandbreakinT.bruceicausesre-localizationofRAD51to
discrete subnuclear foci (Proudfoot and McCulloch, 2005;
Gloveret al.,2008).Formationofsuchfociappearstobea
conservedresponsetoDNAdamagethatiscontrolledbya
number of factors (see Lisby and Rothstein, 2004; Tarsou-
nas et al., 2004 for reviews), including BRCA2 in other
eukaryotes (Tarsounas et al., 2003; Yu et al., 2003; Kojic
et al., 2005; Martin et al., 2005). To examine if this is true
also in T. brucei, we examined RAD51 localization by
indirect immunoﬂuorescence, before and after phleomycin
treatment, in the BRCA2 mutants (Fig. 6). As we have
described before, very few RAD51 foci were detectable in
the absence of damage (only around 3–10% of cells),
whereas treatment with 1.0 mgm l -1 phleomycin for 18 h
resulted in detectable foci in > 75% of WT, +/- and full-
length TbBRCA2 -/-/+ cells (Fig. 6B). In contrast, no evi-
dence was found for RAD51 foci induction in the brca2-/-
cells, suggesting that BRCA2 has a profound role in this
response(Fig. 6B).The-/-cellsinwhicheitherTvBRCA2,
the 1BRC variant or the BRCrep truncation was expressed
displayed a similar deﬁciency in RAD51 foci formation
(Fig. 6). In contrast, BRC–RPA was capable of supporting
foci formation (Fig. 6A), despite being impaired in homolo-
gousintegration.Quantiﬁcationoftheresponseofthe-/-/+
BRC–RPAcells showed they were, in fact, somewhat less
efficient at making RAD51 foci than WT cells (Fig. 6B),
whichcorrelatesthepartiallyincreasedsensitivitytophleo-
mycin we have observed (C. Hartley and R. McCulloch,
submitted). Nevertheless, as has been described in mam-
malian cells (Saeki et al., 2006) and in U. maydis (Kojic
et al., 2005), a fusion of the T. brucei BRC repeats with a
heterologous DNA-binding domain is capable of func-
tioning in DNA damage repair. Why, then, the T. brucei
BRC–RPA fusion is non-functional in homologous recom-
Fig. 5. BRCA2 variants and polypeptide fusions to assess the
function of the BRC repeats in T. brucei recombination and VSG
switching.
A. Functional domains of BRCA2 variants and polypeptide fusions
analysed by expression in bloodstream stage brca2-/- mutants are
shown. Full-length T. brucei BRCA2 may contain up to 15 BRC
repeats, a conserved DSS1-DNA-binding domain (DBD) and two
putative nuclear localization signals (NLSs). T. vivax BRCA2
displays conservation of the DBD, but has only one BRC repeat
and NLSs have not been predicted. 1BRC differs from full-length T.
brucei BRCA2 only in reduction of the BRC array to a single
repeat. BRCrep is a polypeptide fragment of T. brucei BRCA2
encompassing the BRC repeats and 33 downstream amino acids,
including a bipartite NLS. BRC–RPA is a fusion of the BRCrep
polypeptide to the 50 kDa T. brucei replication protein A subunit.
B. Homologous recombination efficiency was assayed by
determining the number of transformants recovered (per 10
6 cells
put on antibiotic selection) when the construct tub-HYG-tub was
electroporated into wild-type (WT) cells, brca2-/- mutants and -/-
cells expressing the BRCA2 variant polypeptides detailed above
(-/-/+).
C. VSG-switching frequencies of WT (Lister 427) T. brucei cells,
brca2-/- mutants and -/- cells expressing the BRCA2 variant
polypeptides are shown.
Values are the means of at least three independent experiments,
and bars represent standard error.
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(Saeki et al., 2006), is not clear. This may reﬂect differ-
ences in the assays used in Saeki et al. (2006) compared
with here, or distinct activities of the parasite and host
BRCA2 proteins.
T. brucei BRCA2 with a single BRC repeat is functional
in VSG switching
To examine if the BRCA2 variants support VSG switching,
we used the expresser cell lines in Lister 427, rather than
generating equivalent cell lines in strain 3174, thereby
allowing direct comparison with the phenotypic analyses
discussed above. Strain 3174 is useful in analysing VSG
switching as it contains antibiotic resistance markers in
the active VSG ES (encoding VSG221) (McCulloch et al.,
1997), meaning that singular VSG expression in a
population can be selected by antibiotic pressure, and
switched variants allowed to arise over a deﬁned number
of generations by removing that selection. The antibiotic
markers can also be used to characterize the switching
events that gave rise to clonal switched variants, which
are recovered by immune selection in vivo. Lister 427 also
expresses the VSG221 ES, but it is not genetically
marked, so exclusive expression cannot be maintained
and examination of VSG switching is limited to measuring
VSG-switching frequency. Before analysing VSG switch-
ing, we ﬁrst conﬁrmed, by Western analysis, that VSG221
continued to be expressed in each expresser cell line
(data not shown). We then followed an abridged version of
the strain 3174 VSG-switching assay described previ-
ously (McCulloch et al., 1997; McCulloch and Barry,
1999). Although there was greater variation, the VSG-
switching frequency determined for WT Lister 427 cells
(Fig. 5C) was comparable with WT 3174 (see Fig. 4), and
the brca2-/- mutants were still seen to be impaired
(Fig. 5C). Strikingly, both cell lines expressing a BRCA2
variant with a single BRC repeat, and the cells expressing
the BRC–RPA fusion, were unaltered in their capacity to
undergo VSG switching relative to either the WT cells or
the -/-/+ TbBRCA2 cells (Fig. 5C). Only the cells express-
ing the isolated BRC repeat domain were impaired in VSG
switching. These results indicate that the tandem array of
identical BRC repeats in T. brucei BRCA2, despite being
crucial for efficient plasmid integration, re-localization of
RAD51 following phleomycin damage and DNA repair
(C. Hartley and R. McCulloch, unpublished), is not a
determinant of VSG switching efficiency during an acute
infection.
T. brucei BRCA2 mutants display gross chromosomal
rearrangements in their megabase chromosomes
BRCA2 mutation in mammalian cells causes accumula-
tion of aberrant chromosomes, including chromosome
loss, breakage and translocations (Patel et al., 1998; Yu
et al., 2000). Similar gross chromosomal rearrangements
(GCRs) have been described in U. maydis BRCA2/Brh2
mutants (Kojic et al., 2002). To examine this in T. brucei,
each of the +/- and -/- BRCA2 cells lines, as well as WT
Fig. 6. RAD51 subnuclear foci in T. brucei bloodstream stage cells.
A. An example of a wild-type (WT) T. brucei cell with discernible subnuclear RAD51 foci following 18 h growth in 1.0 mgm l
-1 phleomycin is
shown (top). Below are examples of brca2-/- cells expressing either T. vivax BRCA2, T. brucei BRCA2 with only one BRC repeat (1BRC) or a
fusion of the T. brucei BRC repeats of BRCA2 and RPA following the same treatment. Cells were visualized by differential interference
contrast (DIC; left), the DNA was stained with DAPI (right centre) and RAD51 (left centre) was visualized by indirect immunoﬂuorescence.
Merged DAPI and RAD51 images are also shown (right).
B. Quantiﬁcation of the number of RAD51 foci detectable after 18 h growth in differing concentrations of phleomycin (BLE; mgm l
-1); BRCA2
variants expressed in the brca2-/- cells (indicated by -/-/+) are detailed in Fig. 5.
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The cells were then re-cloned, and the karyotypes of a
number of clones were analysed by Pulsed Field Gel
(PFG) electrophoresis (Fig. 7A). The megabase chromo-
somes of T. brucei range in size from ~1 to 6 Mb in Lister
427 strain (Melville et al., 2000), and in this gel separation
the greatest size discrimination is seen from ~1 to 2.5 Mb.
Considerable variation in chromosome size between
brca2-/- clones, indicative of GCR, was apparent even
from ethidium bromide staining (particularly mutant 2), in
contrast to the relative stability in the +/- or WT clones.
However, closer examination suggests two things. First,
most such GCR involved reduction in chromosome size.
Second, a trend towards reduction in chromosome
size, though not as severe as the -/- clones, was also
apparent in the BRCA2+/- cells, perhaps indicative of
haploinsufficiency. Probing the PFGs with VSG121
(a ﬁve-gene family), VSG221 (a single-copy VSG in the
Fig. 7. Karyotype changes in BRCA2 mutants.
A. The top and bottom panels to the left show ethidium bromide-stained PFG electrophoretic separations of intact chromosomes from clones
of wild-type (WT) cells and from two independently generated BRCA2 heterozygous (+/-) and homozygous (-/-) mutants that had been grown
in vitro for ~290 generations; size markers (Mb) are shown, and lane numbers are indicated. To the right of this are three Southern blots in
which the PFGs were probed, successively, with VSG121, VSG221 and glucose 6-phosphate isomerase (GPI).
B. A Southern blot of XmnI-digested genomic DNA from samples of the WT, +/- and -/- mutant clones (above). The DNA was separated on a
0.8% agarose gel and the blot probed with VSG121, of which one telomeric (TEL) and four putative subtelomeric array copies are present
(Ii–iv). Size markers (kb) and lane numbers are indicated, and clones in which at least one gene copy had been deleted are indicated by
asterisks.
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glucose 6-phosphate isomerase) appears to conﬁrm
these ﬁndings. Only in two clones (lanes 19 and 21), when
probed with VSG221, did we ﬁnd evidence for an increase
in chromosome size. VSG121 hybridizes to two chromo-
somes of approximately 2.1 and 2.3 Mb, and both appear
to be smaller in all the brca2-/- clones relative to the WT
cells (by as much as 100 kb in some cases). The same
chromosomes also appear to have become smaller in two
to three of the ﬁve BRCA2+/- clones, though to a lesser
extent. The VSG221 and GPI blots show that the extent of
size change in the chromosomes of the brca2-/- cells can
be very severe (for instance, around 500 kb in three
brca2-/- clones probed with VSG221). In addition, the
smaller homologue of chromosome 1 that harbours GPI
(around 2.3 Mb) appears to have reduced in size in three
to four of the ﬁve BRCA2+/- clones. A Southern blot of
XmnI-digested genomic DNAfrom all of the above clones,
probed with VSG121, conﬁrms that the chromosomal
changes can involve loss of genetic material, as 11 of the
12 brca2-/- clones had lost at least one of the ﬁve gene
copies (Fig. 7B). Notably, in no case was the telomeric
copy lost, despite the gene being silent in this strain.
Indeed, all clones continued to express VSG221 (data not
shown), consistent with telomeric sequences being rela-
tively stable.
Remarkably, the same GCRs were not observed in
karyotyping of either the intermediate or minichromo-
somes (Fig. 8). For both these classes of chromosome,
which contain primarily VSG and VSG ES sequences as
the main genetic material that can be expressed, the
karyotype was substantially more stable than the mega-
base chromosomes in the brca2-/- mutants, with no
severe differences in chromosome size detectable com-
pared with the BRCA2+/- and WT cells. This indicates
that although BRCA2 mutation in T. brucei results in
GCRs, this is limited, at least predominantly, to the mega-
base chromosomes.
Discussion
In this report we have characterized a homologue of
BRCA2 in the parasite T. brucei and document the func-
tion of the protein in the maintenance of genome stability,
in recombination and in antigenic variation. Although
BRCA2 is widely conserved in the eukaryotic kingdom
(Warren et al., 2002; Lo et al., 2003), T. brucei is arguably
the most diverged eukaryote in which its cellular functions
have been examined. The structural organization of T.
brucei BRCA2 is highly unusual, possessing an expan-
sion in the number of BRC repeat motifs, which are critical
in the interaction of BRCA2 with the key enzyme of
eukaryotic homologous recombination, RAD51 (Pellegrini
and Venkitaraman, 2004; Shivji and Venkitaraman, 2004;
Sung and Klein, 2006). Most characterized single-celled
eukaryotes encode BRCA2 homologues with one to three
BRC repeats, in contrast with the majority of multicellular
eukaryotes, where BRCA2 normally has three or more
BRC repeats (Lo et al., 2003). The BRC repeat number in
T. brucei BRCA2 is variable between different strains and
subspecies of the parasite, but is always between three-
and sixfold greater than found in most single-celled organ-
isms (with the exception of apicomplexans and T. vagina-
lis; see below), and in some strains is greater than has
been described anywhere else in nature. Given that this
expansion appears not to be present in closely related
kinetoplastid organisms, and that the BRC repeat organi-
zation takes the form of a tandem array of repeats that are
virtually identical in sequence (which contrasts with the
dispersed, diverged repeats found in most other organ-
isms) this appears to be a recent evolutionary adaptation.
The high-sequence homology of the BRC repeats most
likely results in ongoing array expansion and contraction,
explaining the variation in repeat number we have
documented.
No work to date has examined why some BRCA2 mol-
ecules require multiple BRC repeats while others function
with as few as one repeat. The simplest explanation is
that, in general, the evolution of eukaryotes with increas-
ing genome size and developmental complexity requires
greater control or greater overall activity of homologous
recombination, which is reﬂected in more extensive inter-
actions between BRCA2 and RAD51. For example, a
larger number of BRC motifs might be needed to seques-
ter the putatively greater amount of RAD51 until it is
needed for repair, perhaps preventing uncontrolled
recombination. This would be compatible with the demon-
stration that the BRC repeats can disrupt the RAD51
ﬁlament, block its assembly and impair recombination,
Fig. 8. T. brucei intermediate and minichromosomes in BRCA2
mutants. The panels show ethidium bromide-stained PFG
electrophoretic separations of intermediate chromosomes (Inter)
and minichromosomes (Mini) from clones of wild-type (WT) cells
and from two independently generated BRCA2 heterozygous (+/-)
and homozygous (-/-) mutants that had been grown in vitro for
~290 generations; size markers (kb) are shown.
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monomer via the BRC repeats (Chen et al., 1999; Davies
et al., 2001; Pellegrini et al., 2002; Shin et al., 2003).
Indeed, studies of GFP-labelled RAD51 have suggested
that some RAD51 exists in the mammalian nucleus in
relatively immobile pools, one of which is BRCA2-bound,
as well as in another pool of relatively greater mobility
(Essers et al., 2002; Yu et al., 2003). Alternatively, the
number of BRC repeats may vary to ensure that sufficient
RAD51 is available at the site of DNA double strand
breaks, the abundance of which might be dependent on
genome size and/or sequence complexity (Pellegrini
et al., 2002). Such an explanation implies that BRCA2–
RAD51 interaction involves more than just sequestration,
for which there is accumulating evidence. It is now clear
that RAD51 binding to BRCA2 through non-BRC
sequences in both mammals (Davies and Pellegrini,
2007; Esashi et al., 2007) and C. elegans (Petalcorin
et al., 2007) is speciﬁc for, and stabilizes, RAD51
ﬁlaments. In vitro studies have also shown that isolated
BRC motifs can, in some conditions, bind RAD51 ﬁla-
ments without causing disruption (Galkin et al., 2005),
and that a polypeptide from Homo sapiens BRCA2 span-
ning all eight BRC repeats can promote RAD51 strand
exchange (Shivji et al., 2006). Furthermore, a fusion of
the BRC repeats from either H. sapiens (Saeki et al.,
2006) or U. maydis (Kojic et al., 2005) BRCA2 with RPA,
thereby excluding non-BRC-RAD51 binding motifs, also
functions in DNA repair and recombination. These data
indicate that BRC-RAD51 binding can play an active role
in RAD51 recombination, perhaps during the delivery of
RAD51 to sites of damage through BRCA2 binding to
single-strand DNA tails (Yang et al., 2005).
The evolutionary pressures that have dictated the
expansion of BRC repeat numbers in T. brucei are
unknown, but could either reﬂect speciﬁc aspects of the
biology of this parasite or reveal general aspects of
BRCA2 function. The hypothesis we sought to test is that
the BRC repeat expansion is a consequence of antigenic
variation. VSG switching is, at least in part, reliant on
RAD51-dependent homologous recombination, as muta-
tion of RAD51 impairs the process (McCulloch and Barry,
1999), as does mutation of the RAD51 paralogue
RAD51-3 (Proudfoot and McCulloch, 2005). The work
here adds to that picture by showing that BRCA2 is also
critical for efficient VSG switching, as brca2-/- mutants
are signiﬁcantly impaired in this reaction. It should be
noted that the impairment of VSG switching in all these
DNA repair mutants appears to affect the activation of
new VSGs both by gene conversion and by transcriptional
switching between VSG ESs, questioning whether these
reactions are enzymatically and mechanistically distinct
(Proudfoot and McCulloch, 2005). Irrespective of this,
antigenic variation can occur at rates measured to be
substantially greater than background mutation (Turner
and Barry, 1989), are primarily driven by gene conversion
(Robinson et al., 1999) and involve the activation of VSGs
from an archive of silent genes numbering > 1000 and
found dispersed throughout the subtelomeres of most, if
not all, T. brucei chromosomes (Barry et al., 2005; Mar-
cello and Barry, 2007). Any, and perhaps all, of these
factors might explain why BRCA2 in T. brucei has evolved
such a specialized structure. However, we ﬁnd that
BRCA2 with only one BRC repeat, either retaining only
the divergent C-terminal repeat or being BRCA2 from T.
vivax, is capable of supporting efficient VSG switching.
This suggests that the expanded BRC repeat number of T.
brucei BRCA2 is not a consequence of antigenic varia-
tion, with two important caveats. First, we have examined
VSG switching in Lister 427, a monomorphic strain that
undergoes VSG switching at rates of only around 1 ¥ 10-6
switches per cell per generation (see Figs 4 and 8), less
than the pleomorphic cells in which high switching rates
(up to 1 ¥ 10-2) were measured. However, the BRC repeat
number of BRCA2 in Lister 427 is among the highest we
characterized, and BRC numbers vary considerably in T.
brucei, which appears to suggest that the selective pres-
sures that expanded the BRC array are retained in low-
switching strains. Second, our assay measures VSG
switching only very early in an infection, when telomere-
proximal, intact VSG genes are predominantly activated
(Pays, 1989; Morrison et al., 2005; Marcello and Barry,
2007). Later in infections VSG pseudogenes and gene
fragments become the preferred substrates for switching
(Thon et al., 1990; Marcello and Barry, 2007) and it is
therefore possible that T. brucei BRCA2 structure reﬂects
distinctive features of these reactions.
The ﬁnding that VSG switching may not be the basis for
the unusual structure of T. brucei BRCA2 has further
support. T. congolense and T. vivax are closely related to
T. brucei and also survive in mammals through antigenic
variation of a VSG surface coat, which in T. congolense
has been shown to involve gene duplication (Majiwa
et al., 1985). Despite this, the BRCA2 orthologues of
these species possess two to three and one BRC repeats,
respectively, which is more typical of single-celled
eukaryotes. It is worth noting, however, that the genome
annotation of T. congolense BRCA2 predicts three highly
related BRC repeats present in an array, perhaps indicat-
ing an abridged version of the BRC expansion in T. brucei.
It will be interesting to see how the size and organization
of the VSG system in these parasites relate to T. brucei.
Nevertheless, BRC repeat expansion in protists is not
limited to T. brucei. Previous work showed that BRCA2
homologues in Plasmodium have six BRC repeats
(Lo et al., 2003), and we now show that this may be a
common feature of Apicomplexans. Furthermore, T. vagi-
nalis BRCA2 appears to possess 14 BRC repeats.
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shares a functional basis with T. brucei is unknown.
Our data illustrate that, whatever the basis for the selec-
tion of BRC repeat expansion, this structural organization
of T. brucei BRCA2 is critical for general repair and
recombination. BRCA2 with a single repeat does not
support efficient homologous recombination and impairs
the ability of the cell to repair both MMS and phleomycin-
induced DNA damage (C. Hartley and R. McCulloch,
submitted). Most likely, this reﬂects impaired BRCA2 inter-
action with RAD51, as visible re-localization of RAD51 to
subnuclear foci following phleomyin damage was only
seen in parasites expressing full-length TbBRCA2 or
BRC–RPA. Why, then, can BRCA2 with only one BRC
support efficient VSG switching? A number of possibilities
might be considered. The ﬁrst is that general repair/
recombination and antigenic variation have differing
requirements, the former involving extensive interaction
between BRCA2 and RAD51 through a large number of
BRC repeats and the latter needing less extensive
interaction. A second possibility is that the BRC repeat
organization of T. brucei BRCA2 represents a dichotomy
in function between the majority, conserved repeats and
the downstream divergent repeat: for instance, the former
class may provide interactions with RAD51 interaction
that directs general repair/recombination, while the latter
have evolved for a speciﬁc form of RAD51 interaction
during antigenic variation. For either of these scenarios to
be true, antigenic variation in T. vivax and T. congolense
must differ from that of T. brucei and such a distinction
from general repair/recombination must be absent. A ﬁnal
possibility therefore is that the T. vivax BRCA2 protein
and the T. brucei variant retaining only the divergent
C-terminal BRC repeat do not interact with T. brucei
RAD51 sufficiently to mediate repair/recombination. If
correct, the ability of these proteins to support VSG
switching is perplexing, but may suggest that the reaction
involved (which is mediated by RAD51, RAD51-3 and
BRCA2) has signiﬁcant mechanistic distinctions from
general recombination pathways in the parasite. In this
light, it is worth noting that two further proteins that act in
general repair and recombination in T. brucei, RAD51-5
and MRE11 (Robinson et al., 2002; Proudfoot and
McCulloch, 2005), appear not to inﬂuence VSG switching.
Further work will be required to evaluate the above
hypotheses. Examining the unusual BRC repeat expan-
sion of T. brucei BRCA2 could shed light on both the
biochemistry of recombination during antigenic variation
and the evolution of BRCA2 for recombination in general.
For instance, it is intriguing that the GCRs found in the
T. brucei brca2-/- mutants were very similar to those
described previously in mutants of MRE11 (Robinson
et al., 2002). In each case the chromosome size changes
were primarily due to sequences loss, telomeric elements
appeared to be relatively unaffected and rearrangements
were only clearly seen in the megabase chromosomes. It
is tempting to speculate that this indicates a shared func-
tion of the proteins in maintenance or use of the subtelo-
meric VSG arrays, but it is also possible that this reﬂects
broadly conserved roles in genome stability.
Experimental procedures
Assaying recombination and VSG switching
Trypanosoma brucei Lister 427 bloodstream cells of strains
MITat1.2a and 3174 (McCulloch et al., 1997) were grown at
37°C in HMI-9 medium (Hirumi and Hirumi, 1989) and trans-
formed by electroporation as described previously (Conway
et al., 2002; Bell and McCulloch, 2003). Details of the
generation of BRCA2 mutants are described elsewhere
(C. Hartley and R. McCulloch, submitted). To assay recom-
bination, 5 ¥ 10
7 cells of each cell line, grown to a maximum
of 2 ¥ 10
6 cells ml
-1, were transformed with 5 mg of XhoI- and
XbaI-digested tub-HYG-tub, recovered in non-selective
media for three generations (taking account of growth rate)
and transformants were selected with 5 mgm l
-1 hygromycin.
For WT and +/- cells, 5 ¥ 10
6 electroporated cells were plated
over 24 wells in 1.5 ml well
-1, whereas 2 ¥ 10
7 -/- cells were
plated over 48 wells. VSG-switching frequencies in 3174 cell
lines were determined as described previously (McCulloch
and Barry, 1999; Proudfoot and McCulloch, 2005; 2006). For
the Lister 427 MITat1.2a cell lines, essentially the same pro-
cedure was used, but with some modiﬁcations. At least three
mice were infected with 2 ¥ 10
5 cells of each BRCA2 variant
cell line, and the infections cured by cymelarsan treatment
after the parasitaemia reached > 5 ¥ 10
7 cells ml
-1 of blood,
generating mice immune to the VSGs expressed. To select
for switched variants, 4 or 8 ¥ 10
7 cells of each BRCA2
variant cell line (growing in vitro) were inoculated into a
mouse previously infected with the same variant, and recov-
ered 24 h later by exsanguination. The number of switched
variants in the blood was measured as described previously
(McCulloch and Barry, 1999; Proudfoot and McCulloch, 2005;
2006). Details of the BRCA2 variant constructs and targeting
are described elsewhere (C. Hartley and R. McCulloch,
submitted).
MVR mapping
For each T. brucei strain or subspecies, the BRCA2 ORF was
PCR-ampliﬁed from genomic DNA with Taq DNA Polymerase
(ABgene) and the primers TbBRCA2for (5′-ATGAGCCAC
AAAAAAGGAAGACAAGGC) and TbBRCA2rev (5′-TTCT
CGCATAAGATCAGCG) to provide a substrate for MVR PCR
reactions, which contained 5 mM primers TbBRCrepfor (5′-
GCGGTACAAGGAAATTCCAC) and TbBRCreprev (5′-AGG
AGGCACCTGCTCCCGAA) and 5 U of Taq DNA polymerase
(ABgene). MVR PCR was performed in 75 mM Tris-HCl
(pH 8.8), 20 mM (NH4)2SO4, 0.01% (v/v) Tween-20 and
1.5 mM MgCl2 for 18, 21 or 28 cycles of 95°C for 1 min, 55°C
for 1 min and 72°C for 4 min, and the products were sepa-
rated by 1.5% agarose gel electrophoresis.
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Trypanosoma brucei in culture were harvested by centrifuga-
tion at 583 g for 10 min at room temperature, washed in PBS
and re-suspended in 100 ml of PBS. One millilitre of 1% (v/v)
formaldehyde in PBS was added and the sample incubated
at 4°C for 1 h. The cells were then centrifuged at 6000 g for
1 min, washed twice in chilled PBS, washed once in 500 mlo f
chilled 1% BSA in H2O, re-suspended in 30 ml of the same
solution and smeared across a slide and allowed to air dry for
3 h. After re-hydration in PBS for 5 min, the slides were
blocked by adding 50% fetal bovine serum in PBS (FBS/PBS)
for 15 min. Blocking solution was then removed and the
slides were transferred to a dark, humid chamber before
adding rabbit polyclonal anti-TbRAD51 antibody (Proudfoot
and McCulloch, 2005) diluted 1:500 in 3% FBS/PBS for
45 min. The slides were then washed twice in PBS for 5 min,
returned to the humid chamber and Alexa 488-conjugated
goat-derived anti-rabbit IgG, diluted 1:1000 in 3% FBS/PBS,
added and incubated for 45 min at room temperature. Finally,
the slides were washed twice in PBS for 5 min, allowed to air
dry, then mounted in Vectashield with DAPI (4,6-diamidino-
2-phenylindole) (Vector Laboratories). Fluorescence micro-
scopic analysis was performed using an Axioskop 2
microscope (Zeiss) and images were obtained with Openlab
software (Improvision).
PFG electrophoresis
Agarose plugs containing genomic DNA from 5 ¥ 10
7 cells
were prepared as described previously (Barnes and McCul-
loch, 2007). A CHEF-DR III (Bio-Rad) apparatus was used
for electrophoretic separation. 1¥ TB1/10E (90 mM Tris
base, 90 mM boric acid, 2 mM EDTA) and 1.2% agarose
(Seakem LE, BioWhittaker Molecular Applications) was
used for the separation of megabase chromosomes,
whereas 0.5¥ TBE (45 mM Tris base, 45 mM boric acid,
10 mM EDTA) and 1.0% agarose was used for the separa-
tion of smaller chromosomes. Agarose plugs were prepared
by three rounds of dialysis in the appropriate electrophore-
sis buffer. Gels were electrophoresed at 15°C, either at
2 . 5Vc m
-1 for 144 h with an initial switch time of 1400 s and
ﬁnal switch time of 700 s for separation of megabase chro-
mosomes, or 5.8 V cm
-1 for 24 h with initial and ﬁnal switch
times of 20 s for separation of smaller chromosomes. DNA
was visualized by UV illumination following staining of the
gels in 0.2 mgm l
-1 ethidium bromide. Southern blots were
prepared by capillary transfer onto hybond-XL membrane
(Amersham), and were probed with [a-
32P]-labelled DNA
generated by random priming and washed to 0.2¥ SSC,
0.1% SDS at 65°C.
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